|
ATAD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.32747196252603E-15 |
| Normal-vs-Stage2 |
2.30699999999029E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
6.044400E-01 |
| Stage1-vs-Stage3 |
7.51690000000416E-05 |
| Stage1-vs-Stage4 |
1.368760E-04 |
| Stage2-vs-Stage3 |
1.032010E-02 |
| Stage2-vs-Stage4 |
7.475300E-03 |
| Stage3-vs-Stage4 |
8.611000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
7.4502004565602E-10 |
| Normal-vs-Asian |
2.727900E-02 |
| Caucasian-vs-AfricanAmerican |
6.128000E-01 |
| Caucasian-vs-Asian |
2.864800E-01 |
| AfricanAmerican-vs-Asian |
3.798800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.66411329161065E-12 |
| Male-vs-Female |
1.105790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.47210000248188E-08 |
| Normal-vs-Age(41-60Yrs) |
1.76603176527124E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
6.2095000252782E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.292400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.800000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.208600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.906400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.221830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.208200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.417600E-02 |
| Normal-vs-Grade 2 |
9.61699608836852E-11 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
2.947200E-01 |
| Grade 1-vs-Grade 3 |
5.716800E-03 |
| Grade 1-vs-Grade 4 |
2.377100E-04 |
| Grade 2-vs-Grade 3 |
8.010600E-04 |
| Grade 2-vs-Grade 4 |
7.5062000004511E-07 |
| Grade 3-vs-Grade 4 |
2.133600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.18001180943384E-12 |
| Normal-vs-ccB subtype |
1.66067160023431E-12 |
| ccA subtype-vs-ccB subtype |
1.113020E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63513647066793E-12 |
| Normal-vs-N1 |
3.00509999995313E-07 |
| N0-vs-N1 |
2.650800E-01 |
|
|
